Sugden M C, Lall H S, Harris R A, Holness M J
Department of Diabetes and Metabolic Medicine, Division of General and Developmental Medicine, St Bartholomew's and the Royal London School of Medicine and Dentistry at Queen Mary and Westfield College, London E1 4NS, UK.
J Endocrinol. 2000 Nov;167(2):339-45. doi: 10.1677/joe.0.1670339.
The pyruvate dehydrogenase kinases (PDK1-4) regulate glucose oxidation through inhibitory phosphorylation of the pyruvate dehydrogenase complex (PDC). Immunoblot analysis with antibodies raised against recombinant PDK isoforms demonstrated changes in PDK isoform expression in response to experimental hyperthyroidism (100 microg/100 g body weight; 3 days) that was selective for fast-twitch vs slow-twitch skeletal muscle in that PDK2 expression was increased in the fast-twitch skeletal muscle (the anterior tibialis) (by 1. 6-fold; P<0.05) but not in the slow-twitch muscle (the soleus). PDK4 protein expression was increased by experimental hyperthyroidism in both muscle types, there being a greater response in the anterior tibialis (4.2-fold increase; P<0.05) than in the soleus (3.2-fold increase; P<0.05). The hyperthyroidism-associated up-regulation of PDK4 expression was observed in conjunction with suppression of skeletal-muscle PDC activity, but not suppression of glucose uptake/phosphorylation, as measured in vivo in conscious unrestrained rats (using the 2-[(3)H]deoxyglucose technique). We propose that increased PDK isoform expression contributes to the pathology of hyperthyroidism and to PDC inactivation by facilitating the operation of the glucose --> lactate --> glucose (Cori) and glucose --> alanine --> glucose cycles. We also propose that enhanced relative expression of the pyruvate-insensitive PDK isoform (PDK4) in skeletal muscle in hyperthyroidism uncouples glycolytic flux from pyruvate oxidation, sparing pyruvate for non-oxidative entry into the tricarboxylic acid (TCA) cycle, and thereby supporting entry of acetyl-CoA (derived from fatty acid oxidation) into the TCA cycle.
丙酮酸脱氢酶激酶(PDK1 - 4)通过对丙酮酸脱氢酶复合体(PDC)的抑制性磷酸化作用来调节葡萄糖氧化。用针对重组PDK亚型的抗体进行免疫印迹分析表明,实验性甲状腺功能亢进(100μg/100g体重;3天)会导致PDK亚型表达发生变化,这种变化在快肌与慢肌骨骼肌中具有选择性,即快肌骨骼肌(胫前肌)中PDK2表达增加(1.6倍;P<0.05),而慢肌(比目鱼肌)中未增加。实验性甲状腺功能亢进使两种肌肉类型中的PDK4蛋白表达均增加,胫前肌的反应更大(增加4.2倍;P<0.05),大于比目鱼肌(增加3.2倍;P<0.05)。在清醒不受限制的大鼠体内(使用2 - [³H]脱氧葡萄糖技术)测量发现,甲状腺功能亢进相关的PDK4表达上调与骨骼肌PDC活性的抑制相关,但与葡萄糖摄取/磷酸化的抑制无关。我们认为,PDK亚型表达增加通过促进葡萄糖→乳酸→葡萄糖(科里循环)和葡萄糖→丙氨酸→葡萄糖循环的运作,导致甲状腺功能亢进的病理变化和PDC失活。我们还认为,甲状腺功能亢进时骨骼肌中对丙酮酸不敏感的PDK亚型(PDK4)相对表达增强,使糖酵解通量与丙酮酸氧化解偶联,节省丙酮酸用于非氧化进入三羧酸(TCA)循环,从而支持乙酰辅酶A(源自脂肪酸氧化)进入TCA循环。